Metabolic characteristics and identification of antidepressant functional ingredients and their pharmacological mechanisms during the development of flower buds in Hemerocallis citrina

Abstract

The flower bud of Hemerocallis citrina is a health-promoting food with antidepressant properties. However, the differences in metabolic and antidepressant components in flower buds at different developmental stages have not been fully understood. In this study, the changes in metabolic components, antidepressant ingredients, and their pharmacological mechanisms were systematically investigated using "multi-omics" and network pharmacology techniques. The results showed that the contents of at least 220 metabolic components underwent significant alterations during bud development. In particular, there were 81 differential metabolites from maturity (HCB1) to bloom (HCF1), involving 131 differentially expressed genes, 58 differential enzyme proteins, and 19 differential miRNAs, which were jointly involved in the metabolic regulation of galactose, flavonoids, sugars, and amino acids. The study also identified 43 potential antidepressant active ingredients and 26 key targets in the flower buds, which mainly exert their antidepressant effects by regulating important signaling pathways such as the PI3K-Akt and cAMP pathways.

Keywords: Depression; Hemerocallis citrina; Metabolomics; Pharmaceutical effects; RNA-Seq.